Capskii Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.45 M
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 30.51%
- Profit Growth -8.12%
- Ebitda -6.80%
- Net Worth 49.70%
- Total Assets 10.73%
About Capskii Pharmaceuticals
Capskii Pharmaceuticals Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 August 2014 and has a history of Ten years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.45 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Gupta and Sangeeta Gupta serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51909DL2014PTC270541
-
Company No.
270541
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Aug 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Capskii Pharmaceuticals Private Limited offer?
Capskii Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant, Psoriasis Ointment, Digestive System Drugs & Medicines, Antacid Drugs, Anti Infective Drugs & Medicines.
Who are the key members and board of directors at Capskii Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Gupta
|
Director | 19-Aug-2014 | Current |
|
Sangeeta Gupta
|
Director | 12-Feb-2024 | Current |
Financial Performance of Capskii Pharmaceuticals.
Capskii Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 30.51% increase. The company also saw a slight decrease in profitability, with a 8.12% decrease in profit. The company's net worth Soared by an impressive increase of 49.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Capskii Pharmaceuticals?
In 2017, Capskii Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Capskii Pharmaceuticals?
Unlock and access historical data on people associated with Capskii Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Capskii Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Capskii Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
